Does Pregabalin Have Neuropsychotropic Effects?: A Short Perspective
David M. Marks, Ashwin A. Patkar, Prakash S. Masand, Chi-Un Pae
Psychiatry Investig. 2009;6(2):55-58.   Published online 2009 Jun 30     DOI:
Green synthesis of pregabalin‐stabilized gold nanoclusters and their applications in sensing and drug release
Reham Ali, Bayader Alfeneekh, Sridevi Chigurupati, Sayed M. Saleh
Archiv der Pharmazie.2022;[Epub]     CrossRef
Fever in a patient with osteomyelitis: the diagnosis could be serotonin syndrome
Matthew Gould, William D Harrison, Abbey Cahill-Kearns, Greg Barton
BMJ Case Reports.2021; 14(2): e239152.     CrossRef
Pregabalin-associated movement disorders: A literature review
JamirPitton Rissardo, AnaLetícia Fornari Caprara
Brain Circulation.2020; 6(2): 96.     CrossRef
The Accuracy of a Fibromyalgia Diagnosis in General Practice
Rosalind Gittins, Molly Howard, Ameer Ghodke, Timothy J Ives, Paul Chelminski
Pain Medicine.2018; 19(3): 491.     CrossRef
Common Ribs of Inhibitory Synaptic Dysfunction in the Umbrella of Neurodevelopmental Disorders
Rachel Ali Rodriguez, Christina Joya, Rochelle M. Hines
Frontiers in Molecular Neuroscience.2018;[Epub]     CrossRef
Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder
Massimiliano Buoli, Alice Caldiroli, Marta Serati
Expert Opinion on Drug Metabolism & Toxicology.2017; 13(3): 351.     CrossRef
A Novel Pregabalin Functionalized Salicylaldehyde Derivative Afforded Prospective Pain, Inflammation, and Pyrexia Alleviating Propensities
Nisar Ahmad, Fazal Subhan, Nazar Ul Islam, Muhammad Shahid, Faiz Ur Rahman, Khwaja Fawad
Archiv der Pharmazie.2017;[Epub]     CrossRef
Pain and Depression: A Neurobiological Perspective of Their Relationship
Changsu Han, Chi-Un Pae
Psychiatry Investigation.2015; 12(1): 1.     CrossRef
Troubles bipolaires et troubles anxieux comorbides : impact pronostique et enjeux therapeutiques
F. Cazard, F. Ferreri
L'Encéphale.2013; 39(1): 66.     CrossRef
Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study
Cristina Dobrea, Massimiliano Buoli, Chiara Arici, Giulia Camuri, Bernardo Dell'Osso, Alfredo Carlo Altamura
Expert Opinion on Drug Safety.2012; 11(6): 893.     CrossRef